Baronsmead Venture Trust PLC Director/PDMR Shareholding

RNS Number : 3002H

Baronsmead Venture Trust PLC

18 March 2024

 

18 March 2024

 

 

BARONSMEAD VENTURE TRUST PLC

("THE COMPANY")

 

The Company was notified on 18 March 2024 that Michael Probin, Non-executive Director of the Company, acquired 3,741 Ordinary shares of 10 pence each in the capital of the Company, through participation in the Company's Dividend Reinvestment Plan, at a price of 55.40 pence per Ordinary share. As a result of this purchase, Mr Probin's aggregate holding of shares in the Company is 83,601 Ordinary shares, representing 0.02% of the Company's issued share capital.

1.	Details of PDMR / person closely associated with them ("PCA")
a)	Name	Michael Probin
2.	Reason for the notification
b)	Position / status	Non-Executive Director
c)	Initial notification / amendment	Initial Notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Baronsmead Venture Trust plc
b)	LEI	213800VQ1PQHOJXDDQ88
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument   Identification Code	Ordinary Shares of £0.10 each     ISIN: GB0002631934
b)	Nature of the transaction	Acquisition of shares through participation in the Dividend Reinvestment Plan
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		£0.5540	3,741
d)	Aggregated information Aggregated volume Price	N/A - single transaction
e)	Date of the transaction	08/03/2024
f)	Place of the transaction	London Stock Exchange (XLON)

 

 

 

For further information please contact:

 

Baronsmead VCT Investor Relations

 

020 7382 0999

 

[e-mail]

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

DSHFLFSRVEITLIS